Brain Health

A new study from Northwestern University offers hope to Alzheimer's patients and their caregivers. If researchers there are correct, their new small-molecule NU-9 drug may be able to stop the disease long before it begins ruining lives.

In a landmark shift in how mental health conditions are treated in the near future, the US Food and Drug Administration has approved the first at-home brain-stimulation device that can rapidly relieve moderate to severe depression symptoms.

ADHD drugs have been thought to sharpen attention, but a new study has found something very different is at play. They don't offer laser-sharp focus but boost wakefulness and engagement, helping the brain stick to tasks it would otherwise give up on.

Researchers at Switzerland’s EPFL have created a new neurotherapy that vastly and non-invasively improves vision for patients with hemianopia-related vision loss. Previously, patients suffering from the condition simply had to learn to live with it.

A new “audio shield” uses earbuds connected to hand-mounted microphones for hearing the subtle sounds of everyday tasks. The mechanism helps users block the perpetual hurricane of distractions and achieve mindfulness, reducing the effects of ADHD.

There's a well-established link between depression and chronic low-grade inflammation. Now, a new meta-study shows that treating the inflammation can reduce depression in two ways, offering a potential alternative to antidepressants and their side effects.

In a breakthrough, scientists have discovered that a variant in one gene can cause mental illnesses – something previously believed to only be the result of several variants working together. What's more, these conditions often develop in childhood.

In a new study, researchers discovered that the human brain has four pivotal periods when it goes through marked changes, sparking five "epochs" that last for years. The adolescent phase, for example, was found to extend into our early 30s.

Scientists have failed to show that weight-loss wonder drug semaglutide can also slow the progress of Alzheimer's disease (AD), as two two-year clinical trials end in disappointment for patients, medical scientists and drugmaker Novo Nordisk.

Groundbreaking research has uncovered three gene variants that increase the risk of attention-deficit/hyperactivity disorder by up to 15 times. It's a remarkable finding, considering that thousands of mutations only come with a nominal elevated risk.

Survivors of childhood trauma experience high risk for depression. If they have high levels of SGK1 in their brain tissue, they’re at greater risk. Combined with genetic screening for the protein, SGK1 inhibitors could be a life-saving intervention.

One of the brain’s biggest benefits from exercise – the birth of new neurons – may not even require any movement. Instead, the beneficial “packages” circulating in the blood after working out can be successfully transferred to others.

Boosting levels of a certain molecule that declines with age restored the function of hundreds of brain genes and reversed memory loss in Alzheimer’s disease models, fixing the RNA splicing errors that drive damage to critical neurons.

Researchers at MIT have created a revolutionary platform to treat a vast array of neurological diseases and mental illnesses. It could not only prove more effective than traditional methods, but also negate the need for invasive brain surgery.

New research has found that the loss of social memory – recognizing friends and family – in Alzheimer's disease (AD) could come down to specific structures around brain cells. And targeting this delicate scaffolding may potentially prevent this heartbreaking stage in cognitive decline.